Serial Analysis of Antimitochondrial Antibody in Patients with Primary Biliary Cirrhosis
2004

Study of Antimitochondrial Antibodies in Primary Biliary Cirrhosis

Sample size: 20 publication Evidence: moderate

Author Information

Author(s): GORDON D. BENSON, KENTARO KIKUCHI, HIROSHI MIYAKAWA, ATSUSHI TANAKA, MITCHELL R. WATNIK, M. ERIC GERSHWIN

Primary Institution: UMDNJ-Robert Wood Johnson Medical School

Hypothesis

The study investigates the changes in titer and isotype analysis of antimitochondrial antibodies in patients with primary biliary cirrhosis over a long follow-up period.

Conclusion

The study found that the titer of antimitochondrial antibodies did not significantly change over time, and higher titers were observed in younger patients.

Supporting Evidence

  • The titer of antimitochondrial antibodies was significantly higher in younger patients.
  • No significant change in antibody levels was noted during the long follow-up period.
  • The study analyzed sera from patients followed for a mean duration of 13.5 years.

Takeaway

Doctors looked at blood samples from patients with a liver disease called primary biliary cirrhosis over many years and found that certain antibodies didn't change much, especially in younger patients.

Methodology

The study used immunoblot and enzyme-linked immunosorbent assays to analyze stored sera from patients followed for 7-28 years.

Limitations

The study may not be entirely representative of the spectrum of disease observed in primary biliary cirrhosis.

Participant Demographics

Nineteen of the twenty patients were women, aged 25 to 73 years at initial evaluation.

Statistical Information

P-Value

0.0002

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1080/10446670410001722113

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication